US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist
  • 0.3174
  • -0.0136-4.11%
Close Dec 20 16:00 ET
  • 0.3330
  • +0.0156+4.91%
Post 20:01 ET
2.00MMarket Cap-0.01P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-37.50%10K
-98.93%4K
29K
420K
31K
16K
373K
0
0
0
Operating revenue
-37.50%10K
-98.93%4K
--29K
--420K
--31K
--16K
--373K
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-68.12%2.19M
-42.11%3.65M
-40.10%4.38M
-6.45%25.87M
-39.05%5.39M
6.09%6.86M
8.94%6.3M
11.59%7.32M
23.52%27.66M
47.79%8.85M
Selling and administrative expenses
-23.88%1.24M
3.17%1.63M
-3.83%1.58M
-8.99%6.72M
-12.60%1.87M
-20.89%1.63M
-0.32%1.58M
2.49%1.65M
-1.06%7.38M
10.41%2.14M
-General and administrative expense
-23.88%1.24M
3.17%1.63M
-3.83%1.58M
-8.99%6.72M
-12.60%1.87M
-20.89%1.63M
-0.32%1.58M
2.49%1.65M
-1.06%7.38M
10.41%2.14M
Research and development costs
-81.86%950K
-57.20%2.02M
-50.62%2.8M
-5.52%19.16M
-47.51%3.52M
18.65%5.24M
12.41%4.73M
14.53%5.67M
35.81%20.27M
65.73%6.7M
Operating profit
68.20%-2.18M
38.54%-3.64M
40.50%-4.36M
7.97%-25.45M
39.40%-5.36M
-5.85%-6.85M
-2.49%-5.93M
-11.59%-7.32M
-23.52%-27.66M
-47.79%-8.85M
Net non-operating interest income expense
-84.00%8K
-136.36%-28K
-98.28%2K
26.67%266K
-81.15%23K
-25.37%50K
352.94%77K
2,800.00%116K
1,212.50%210K
2,950.00%122K
Non-operating interest income
-84.00%8K
----
-98.28%2K
26.67%266K
-81.15%23K
-25.37%50K
352.94%77K
2,800.00%116K
1,212.50%210K
2,950.00%122K
Non-operating interest expense
----
--28K
----
----
----
----
----
----
----
----
Other net income (expense)
-97.89%2K
101.65%3K
-32.91%53K
-123.78%-364K
-28.52%-356K
-67.24%95K
-187.08%-182K
-93.96%79K
714.36%1.53M
-810.26%-277K
Gain on sale of security
-98.08%2K
103.95%3K
101.15%1K
-277.68%-414K
-26.69%-356K
-62.32%104K
-136.36%-76K
-400.00%-87K
429.55%233K
-820.51%-281K
Other non- operating income (expenses)
----
----
-68.67%52K
-96.15%50K
--0
-164.29%-9K
---106K
-87.03%166K
801.39%1.3M
--4K
Income before tax
67.66%-2.17M
39.19%-3.67M
39.64%-4.3M
1.40%-25.55M
36.74%-5.69M
-9.66%-6.7M
-8.54%-6.03M
-35.80%-7.12M
-16.81%-25.92M
-51.46%-9M
Income tax
68.56%-210K
29.69%-412K
-2.58%-1.35M
36.49%-3M
73.31%-422K
34.12%-668K
40.45%-586K
-15.99%-1.32M
-26.53%-4.72M
-46.66%-1.58M
Net income
67.56%-1.96M
40.22%-3.26M
49.24%-2.95M
-6.40%-22.56M
28.95%-5.27M
-18.37%-6.03M
-19.08%-5.45M
-41.29%-5.8M
-14.85%-21.2M
-52.53%-7.42M
Net income continuous Operations
67.56%-1.96M
40.22%-3.26M
49.24%-2.95M
-6.40%-22.56M
28.95%-5.27M
-18.37%-6.03M
-19.08%-5.45M
-41.29%-5.8M
-14.85%-21.2M
-52.53%-7.42M
Minority interest income
Net income attributable to the parent company
67.56%-1.96M
40.22%-3.26M
49.24%-2.95M
-6.40%-22.56M
28.95%-5.27M
-18.37%-6.03M
-19.08%-5.45M
-41.29%-5.8M
-14.85%-21.2M
-52.53%-7.42M
Preferred stock dividends
0.00%201K
0.00%50K
0.00%50K
0.00%50K
0.00%50K
0.00%201K
0.00%50K
Other preferred stock dividends
Net income attributable to common stockholders
67.82%-1.96M
40.76%-3.26M
49.68%-2.95M
-6.34%-22.76M
28.76%-5.32M
-18.19%-6.08M
-18.88%-5.5M
-40.79%-5.85M
-14.69%-21.4M
-51.99%-7.47M
Basic earnings per share
62.50%-0.18
89.04%-0.72
67.57%-2.27
6.79%-26.75
30.78%-6.23
92.56%-0.48
4.78%-6.57
-11.11%-7
8.45%-28.7
-11.11%-9
Diluted earnings per share
62.50%-0.18
89.04%-0.72
67.57%-2.27
6.79%-26.75
30.78%-6.23
92.56%-0.48
4.78%-6.57
-11.11%-7
8.45%-28.7
-11.11%-9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -37.50%10K-98.93%4K29K420K31K16K373K000
Operating revenue -37.50%10K-98.93%4K--29K--420K--31K--16K--373K--0--0--0
Cost of revenue
Gross profit
Operating expense -68.12%2.19M-42.11%3.65M-40.10%4.38M-6.45%25.87M-39.05%5.39M6.09%6.86M8.94%6.3M11.59%7.32M23.52%27.66M47.79%8.85M
Selling and administrative expenses -23.88%1.24M3.17%1.63M-3.83%1.58M-8.99%6.72M-12.60%1.87M-20.89%1.63M-0.32%1.58M2.49%1.65M-1.06%7.38M10.41%2.14M
-General and administrative expense -23.88%1.24M3.17%1.63M-3.83%1.58M-8.99%6.72M-12.60%1.87M-20.89%1.63M-0.32%1.58M2.49%1.65M-1.06%7.38M10.41%2.14M
Research and development costs -81.86%950K-57.20%2.02M-50.62%2.8M-5.52%19.16M-47.51%3.52M18.65%5.24M12.41%4.73M14.53%5.67M35.81%20.27M65.73%6.7M
Operating profit 68.20%-2.18M38.54%-3.64M40.50%-4.36M7.97%-25.45M39.40%-5.36M-5.85%-6.85M-2.49%-5.93M-11.59%-7.32M-23.52%-27.66M-47.79%-8.85M
Net non-operating interest income expense -84.00%8K-136.36%-28K-98.28%2K26.67%266K-81.15%23K-25.37%50K352.94%77K2,800.00%116K1,212.50%210K2,950.00%122K
Non-operating interest income -84.00%8K-----98.28%2K26.67%266K-81.15%23K-25.37%50K352.94%77K2,800.00%116K1,212.50%210K2,950.00%122K
Non-operating interest expense ------28K--------------------------------
Other net income (expense) -97.89%2K101.65%3K-32.91%53K-123.78%-364K-28.52%-356K-67.24%95K-187.08%-182K-93.96%79K714.36%1.53M-810.26%-277K
Gain on sale of security -98.08%2K103.95%3K101.15%1K-277.68%-414K-26.69%-356K-62.32%104K-136.36%-76K-400.00%-87K429.55%233K-820.51%-281K
Other non- operating income (expenses) ---------68.67%52K-96.15%50K--0-164.29%-9K---106K-87.03%166K801.39%1.3M--4K
Income before tax 67.66%-2.17M39.19%-3.67M39.64%-4.3M1.40%-25.55M36.74%-5.69M-9.66%-6.7M-8.54%-6.03M-35.80%-7.12M-16.81%-25.92M-51.46%-9M
Income tax 68.56%-210K29.69%-412K-2.58%-1.35M36.49%-3M73.31%-422K34.12%-668K40.45%-586K-15.99%-1.32M-26.53%-4.72M-46.66%-1.58M
Net income 67.56%-1.96M40.22%-3.26M49.24%-2.95M-6.40%-22.56M28.95%-5.27M-18.37%-6.03M-19.08%-5.45M-41.29%-5.8M-14.85%-21.2M-52.53%-7.42M
Net income continuous Operations 67.56%-1.96M40.22%-3.26M49.24%-2.95M-6.40%-22.56M28.95%-5.27M-18.37%-6.03M-19.08%-5.45M-41.29%-5.8M-14.85%-21.2M-52.53%-7.42M
Minority interest income
Net income attributable to the parent company 67.56%-1.96M40.22%-3.26M49.24%-2.95M-6.40%-22.56M28.95%-5.27M-18.37%-6.03M-19.08%-5.45M-41.29%-5.8M-14.85%-21.2M-52.53%-7.42M
Preferred stock dividends 0.00%201K0.00%50K0.00%50K0.00%50K0.00%50K0.00%201K0.00%50K
Other preferred stock dividends
Net income attributable to common stockholders 67.82%-1.96M40.76%-3.26M49.68%-2.95M-6.34%-22.76M28.76%-5.32M-18.19%-6.08M-18.88%-5.5M-40.79%-5.85M-14.69%-21.4M-51.99%-7.47M
Basic earnings per share 62.50%-0.1889.04%-0.7267.57%-2.276.79%-26.7530.78%-6.2392.56%-0.484.78%-6.57-11.11%-78.45%-28.7-11.11%-9
Diluted earnings per share 62.50%-0.1889.04%-0.7267.57%-2.276.79%-26.7530.78%-6.2392.56%-0.484.78%-6.57-11.11%-78.45%-28.7-11.11%-9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data